Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
Paul Cairns(Johns Hopkins University), David Sidransky(University of Baltimore), William Isaacs(Johns Hopkins University), Adrian Merlo(University Hospital of Basel), William H. Westra(Mount Sinai Hospital), Kathleen R. Cho(University of Michigan), Edward Gabrielson(Johns Hopkins University), Wayne M. Koch(Johns Hopkins University), Robert P. Jenkins(Mayo Clinic), Joseph Califano(Johns Hopkins University), Lora Hedrick(Johns Hopkins Hospital), Mel Tockman(Johns Hopkins University), Alan Buckler(Harvard University), Kaori Tokino(Johns Hopkins University), John F. Herath(Mayo Clinic), Donna Schwab(Johns Hopkins University), Joni L. Rutter(National Institutes of Health), Li Mao(Nanjing University of Chinese Medicine), Yolanda Eby(Johns Hopkins University), Thomas J. Polascik(General Marble (Greece)), G. Steven Bova(Prostate Cancer Research)
Cited by 646
Related Papers
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
The evolutionary history of lethal metastatic prostate cancer
|Nature|2015|1.4k
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
|Nature Genetics|1997|1k
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
|Cancer Discovery|2016|897